With Big Pharma In Retreat, Ackman And Novartis Try A New Blueprint For Drug Companies
4.22.2014 | Forbes
By Steve Brozak
Yesterday in a move that returned attention to healthcare takeovers, Bill Ackman, CEO of the hedge fund Pershing Square Capital, announced a bold and unusual move by partnering with pharmaceutical company, Valeant Pharmaceuticals International, Inc. to acquire a major stake in another biotech. In this case it is Allergan, Inc., the makers of the injectable wrinkle-remover BOTOX, and several ophthalmic treatments.
For the full article, please click here.